• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在肝癌切除术后,细胞角蛋白 19 在淋巴结中的表达是一个预后不良的因素。

The expression of cytokeratin 19 in lymph nodes was a poor prognostic factor for hepatocellular carcinoma after hepatic resection.

机构信息

The Department of Surgery, Chang Gung Memorial Hospital, No 5 Fusing Street, Taoyuan County, Gueishan 333, Taiwan.

出版信息

World J Surg Oncol. 2013 Jun 12;11(1):136. doi: 10.1186/1477-7819-11-136.

DOI:10.1186/1477-7819-11-136
PMID:23758804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3708812/
Abstract

BACKGROUND

The expression of CK19 in primary hepatocellular carcinoma (HCC) is associated with a poor outcome. However, few studies have investigated the expression profile of CK19 in regional lymph nodes (LNs) of HCC after hepatic resection. The purpose of this study was to evaluate the expression of CK19 in primary liver tumor and regional LNs of HCC with and without lymph node metastasis (LNM).

METHODS

The expression of CK19 in patients with (n = 16) and without LNM (n = 26) was examined using immunohistochemical staining. Both the primary tumor and LN specimen were studied for their CK19 expression. Clinico-pathological variables and prognostic significance were analyzed.

RESULTS

Immunopositivity of CK19 in primary liver tumor was significantly correlated with LNM (P = 0.005) and tumor non-encapsulation (P <0.005). Univariate analysis showed that CK19 expression in primary liver tumor, CK19 expression in regional LN, vascular invasion, daughter nodules, positive resection margin and American Joint Committee on Cancer (AJCC) tumor stage significantly decreased overall survival. Multivariate analysis demonstrated that daughter nodules (P = 0.001) and CK19 expression in regional LN (P = 0.002) were independent prognostic factors for overall survival.

CONCLUSIONS

This study showed that CK19 expression in regional LN of HCC was associated with LNM and an extremely poor outcome after operation. It is of clinical significance to identify these patients at risk for more aggressive HCC, and multi-modality treatment could be helpful to improve their dismal outcome.

摘要

背景

在原发性肝细胞癌(HCC)中 CK19 的表达与预后不良相关。然而,很少有研究调查过 CK19 在 HCC 肝切除术后区域淋巴结(LN)中的表达谱。本研究旨在评估 CK19 在伴或不伴淋巴结转移(LNM)的 HCC 原发肿瘤和区域 LN 中的表达。

方法

采用免疫组织化学染色法检测 16 例伴 LNM 和 26 例不伴 LNM 的 HCC 患者的 CK19 表达。对原发肿瘤和 LN 标本均进行 CK19 表达研究。分析临床病理变量和预后意义。

结果

原发肝脏肿瘤中 CK19 的免疫阳性与 LNM(P=0.005)和肿瘤无包膜(P<0.005)显著相关。单因素分析显示,原发肝脏肿瘤中 CK19 的表达、区域 LN 中 CK19 的表达、血管侵犯、子灶、阳性切缘和美国癌症联合委员会(AJCC)肿瘤分期均显著降低了总生存率。多因素分析表明,子灶(P=0.001)和区域 LN 中 CK19 的表达(P=0.002)是总生存率的独立预后因素。

结论

本研究表明 HCC 区域 LN 中 CK19 的表达与 LNM 和术后极差的预后相关。识别这些高危 HCC 患者具有重要的临床意义,多模式治疗可能有助于改善其不良预后。

相似文献

1
The expression of cytokeratin 19 in lymph nodes was a poor prognostic factor for hepatocellular carcinoma after hepatic resection.在肝癌切除术后,细胞角蛋白 19 在淋巴结中的表达是一个预后不良的因素。
World J Surg Oncol. 2013 Jun 12;11(1):136. doi: 10.1186/1477-7819-11-136.
2
Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor.根据肿瘤中细胞角蛋白19(CK19)的表达情况,两种具有淋巴结转移的肝细胞癌病理类型预后不同。
Cancer. 2008 Jun 15;112(12):2740-8. doi: 10.1002/cncr.23488.
3
CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection.CK19和磷脂酰肌醇蛋白聚糖3表达谱在肝癌手术切除患者预后指标中的应用
PLoS One. 2016 Mar 15;11(3):e0151501. doi: 10.1371/journal.pone.0151501. eCollection 2016.
4
Expression of cytokeratin 19 and matrix metalloproteinase 2 predicts lymph node metastasis in hepatocellular carcinoma.细胞角蛋白 19 和基质金属蛋白酶 2 的表达预测肝癌的淋巴结转移。
Mol Biol Rep. 2011 Jun;38(5):3531-9. doi: 10.1007/s11033-010-0463-x. Epub 2010 Nov 23.
5
Combination with CK19 Might Increase the Prognostic Power of Hep Par 1 in Hepatocellular Carcinoma after Curative Resection.与CK19联合使用可能会增强Hep Par 1在肝细胞癌根治性切除术后的预后评估能力。
J Invest Surg. 2018 Oct;31(5):412-419. doi: 10.1080/08941939.2017.1347218. Epub 2017 Jul 31.
6
Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.细胞角蛋白10和细胞角蛋白19:肝细胞癌患者根治性切除术后预后不良的预测标志物。
Clin Cancer Res. 2008 Jun 15;14(12):3850-9. doi: 10.1158/1078-0432.CCR-07-4338.
7
Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma.p53 和 β-catenin 突变与 CK19 表达在肝癌早期复发和预后中的作用。
J Gastrointest Surg. 2011 Feb;15(2):321-9. doi: 10.1007/s11605-010-1373-x.
8
[CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].细胞角蛋白19可用于预测血清甲胎蛋白浓度低的乙肝相关肝细胞癌患者在R0根治性肝切除术后的早期复发及预后
Zhonghua Zhong Liu Za Zhi. 2012 Oct;34(10):753-8. doi: 10.3760/cma.j.issn.0253-3766.2012.10.008.
9
CK19 Predicts Recurrence and Prognosis of HBV Positive HCC.CK19 预测 HBV 阳性 HCC 的复发和预后。
J Gastrointest Surg. 2022 Feb;26(2):341-351. doi: 10.1007/s11605-021-05107-w. Epub 2021 Sep 10.
10
Prognostic implications of CK19 positivity in patients with early recurrent hepatocellular carcinoma after hepatic resection undergoing transarterial chemoembolization.CK19 阳性对接受经肝动脉化疗栓塞治疗的早期复发性肝细胞癌患者的预后意义。
BMC Gastroenterol. 2024 Oct 3;24(1):347. doi: 10.1186/s12876-024-03417-2.

引用本文的文献

1
Development and validation of a combined radiomic and clinical model based on contrast-enhanced ultrasound for preoperative prediction of CK19-positive hepatocellular carcinoma.基于超声造影的联合影像组学和临床模型用于术前预测CK19阳性肝细胞癌的开发与验证
Abdom Radiol (NY). 2025 Feb 5. doi: 10.1007/s00261-025-04799-x.
2
Prognostic implications of CK19 positivity in patients with early recurrent hepatocellular carcinoma after hepatic resection undergoing transarterial chemoembolization.CK19 阳性对接受经肝动脉化疗栓塞治疗的早期复发性肝细胞癌患者的预后意义。
BMC Gastroenterol. 2024 Oct 3;24(1):347. doi: 10.1186/s12876-024-03417-2.
3

本文引用的文献

1
Hepatic resection for hepatocellular carcinoma with lymph node metastasis: clinicopathological analysis and survival outcome.肝细胞癌伴淋巴结转移的肝切除术:临床病理分析与生存结果。
Asian J Surg. 2011 Apr;34(2):53-62. doi: 10.1016/S1015-9584(11)60020-1.
2
Epidermal growth factor induces cytokeratin 19 expression accompanied by increased growth abilities in human hepatocellular carcinoma.表皮生长因子诱导细胞角蛋白 19 的表达,并伴有人类肝癌生长能力的增强。
Lab Invest. 2011 Feb;91(2):262-72. doi: 10.1038/labinvest.2010.161. Epub 2010 Sep 20.
3
[Nuclear accumulation of CXCR4 and overexpressions of VEGF-C and CK19 are associated with a higher risk of lymph node metastasis in hepatocellular carcinoma].
Tumor matrix stiffness provides fertile soil for cancer stem cells.
肿瘤基质硬度为癌症干细胞提供了肥沃的土壤。
Cancer Cell Int. 2023 Jul 20;23(1):143. doi: 10.1186/s12935-023-02992-w.
4
The added value of F-FDG PET/MRI multimodal imaging in hepatocellular carcinoma for identifying cytokeratin 19 status.F-FDG PET/MRI 多模态成像在肝细胞癌中对细胞角蛋白 19 状态的识别价值。
Abdom Radiol (NY). 2023 Jul;48(7):2331-2339. doi: 10.1007/s00261-023-03911-3. Epub 2023 Apr 29.
5
The Role of Radiomics and AI Technologies in the Segmentation, Detection, and Management of Hepatocellular Carcinoma.放射组学和人工智能技术在肝细胞癌的分割、检测及管理中的作用
Cancers (Basel). 2022 Dec 12;14(24):6123. doi: 10.3390/cancers14246123.
6
Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma.上皮细胞黏附分子(Epcam)和CD133的过表达与双表型肝细胞癌的不良预后相关。
J Cancer. 2020 Mar 5;11(11):3400-3406. doi: 10.7150/jca.41090. eCollection 2020.
7
A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.基于影像组学的钆塞酸增强 MRI 肝细胞癌细胞角蛋白 19 状态的生物标志物
Eur Radiol. 2020 May;30(5):3004-3014. doi: 10.1007/s00330-019-06585-y. Epub 2020 Jan 30.
8
Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis.钆塞酸二钠增强 MRI 影像组学在诊断双表型肝细胞癌及患者预后评估中的应用
J Cancer Res Clin Oncol. 2019 Dec;145(12):2995-3003. doi: 10.1007/s00432-019-03062-3. Epub 2019 Oct 29.
9
Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal?正常甲胎蛋白肝细胞癌:它们真的正常吗?
J Clin Med. 2019 Oct 19;8(10):1736. doi: 10.3390/jcm8101736.
10
Clinical significance of cytokeratin in the cervical lymph nodes of patients with mandibular gingival squamous cell carcinoma.细胞角蛋白在下颌牙龈鳞状细胞癌患者颈部淋巴结中的临床意义
Oncol Lett. 2018 Sep;16(3):3135-3139. doi: 10.3892/ol.2018.9005. Epub 2018 Jun 21.
CXCR4的核聚集以及VEGF-C和CK19的过表达与肝细胞癌淋巴结转移风险较高相关。
Zhonghua Zhong Liu Za Zhi. 2010 May;32(5):344-9.
4
Molecular diagnosis of multistage hepatocarcinogenesis.多阶段肝癌发生的分子诊断。
Jpn J Clin Oncol. 2010 Sep;40(9):891-6. doi: 10.1093/jjco/hyq099. Epub 2010 Jul 4.
5
Molecular classification and novel targets in hepatocellular carcinoma: recent advancements.肝细胞癌的分子分类和新靶点:最新进展。
Semin Liver Dis. 2010 Feb;30(1):35-51. doi: 10.1055/s-0030-1247131. Epub 2010 Feb 19.
6
Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor.根据肿瘤中细胞角蛋白19(CK19)的表达情况,两种具有淋巴结转移的肝细胞癌病理类型预后不同。
Cancer. 2008 Jun 15;112(12):2740-8. doi: 10.1002/cncr.23488.
7
Keratin profiles may differ between intraepidermal and intradermal invasive eccrine porocarcinoma.表皮内和真皮内侵袭性小汗腺导管癌的角蛋白谱可能有所不同。
Oncol Rep. 2006 Sep;16(3):473-7.
8
Characterization of two distinct liver progenitor cell subpopulations of hematopoietic and hepatic origins.造血起源和肝脏起源的两种不同肝祖细胞亚群的特征分析。
Exp Cell Res. 2006 Sep 10;312(15):2826-36. doi: 10.1016/j.yexcr.2006.05.007. Epub 2006 May 19.
9
Histological types and significance of bronchial epithelial dysplasia.支气管上皮发育异常的组织学类型及其意义。
Mod Pathol. 2006 Mar;19(3):429-37. doi: 10.1038/modpathol.3800553.
10
Immunohistologic attempt to find carcinogenesis from hepatic progenitor cell in hepatocellular carcinoma.通过免疫组织学方法探寻肝细胞癌中肝祖细胞的致癌机制。
Dig Surg. 2005;22(5):364-70. doi: 10.1159/000090515. Epub 2005 Dec 22.